Congress OKs Last-Minute Fix To Save $250M In FDA Fees

Law360, New York (September 24, 2012, 3:56 PM EDT) -- In a last-minute bid to save $250 million in U.S. Food and Drug Administration user fees from slipping out of the agency's grasp, the Senate approved a bill early Saturday morning that will allow the FDA to collect new generic-drug user fees starting Oct. 1.

A glitch in the user fee bill, known as the FDA Safety and Innovation Act, combined with Congress' decision to use a continuing resolution to fund the government for the next six months, would have prevented the FDA from getting most...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.